Suppr超能文献

低病毒载量抗逆转录病毒治疗患者中HIV耐药性与CD4(+)T细胞计数关系的研究

[Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load].

作者信息

Liu P T, Xing H, Liao L J, Leng X B, Wang J, Kan W, Yan J, Zuo Z B, Ruan Y H, Shao Y M

机构信息

National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):277-281. doi: 10.3760/cma.j.issn.0253-9624.2018.03.011.

Abstract

To explore drug resistance of different viral loads, and investigate the relationship between drug resistance and CD4(+)T cell counts in patients with HIV antiretroviral therapy (ART) in China from 2003 to 2015. Data were extracted from the Chinese National HIVDR Surveillance database from 2003 to 2015. For this study, the data collected were as follows: having received ART for ≥12 months; 18 years or older; demographic characteristics, information of ART, CD4(+)T cell counts, viral load (VL) and HIV drug resistance of a total of 8 362 patients were collected. Multi-variables non-conditional logistic regression model was used to study the relationship between viral load, HIV drug resistance and CD4(+)T cell counts. Participants with age of (41.8±10.5) years were enrolled in this study. Among them, 59.9% (5 009 cases) were men. The percentage of CD4(+)T cell counts <200 cells/μl in the total population was 17.9% (1 496 cases), the highest was in VL ≥1 000 copies/ml with drug resistance, which was 43.0% (397/923) , followed by VL 50-999 copies/ml with drug resistance, which was 31.1% (69/222), and the lowest was in VL 50-999 copies/ml without drug resistance 13.2% (273/2 068). Compared to VL 50-999 copies/ml without drug resistance, VL<50 copies/ml, VL 50-999 with drug resistance, VL≥1 000 copies/ml without drug resistance, and VL ≥1 000 copies/ml with drug resistance, the (95%) of CD4 <200 cells/μl were 0.9 (0.7-1.0), 3.2 (2.3-4.4), 2.6 (2.1-3.2), and 4.9 (4.0-5.9), respectively. Among 222 patients with VL 50-999 and HIVDR, the most frequent antiretroviral drugs were EFV and NVP, both of which were NNRTI, and whose percentage both were 94.1% (209 cases). The most frequent mutations were M184V/I (NNRTI), and the percentage was 26.1% (58 cases). The second one was K103N (NNRTI), and the percentage was 22.5% (50 cases). The percentage of V32L/E (PI) and V82A (PI) were lower, they were 0.9% (2 cases) and 0.5% (1 case) respectively. Decreased CD4(+)T cell counts were associated with HIV drug resistance at low viraemia. In the case of low viral load, the most vulnerable were the NNRTI antiviral drugs such as EFV and NVP.

摘要

探讨不同病毒载量的耐药情况,研究2003年至2015年中国接受抗逆转录病毒治疗(ART)的HIV患者中耐药与CD4(+)T细胞计数之间的关系。数据来自2003年至2015年中国国家HIVDR监测数据库。本研究收集的数据如下:接受ART治疗≥12个月;年龄≥18岁;共收集了8362例患者的人口统计学特征、ART信息、CD4(+)T细胞计数、病毒载量(VL)和HIV耐药情况。采用多变量非条件逻辑回归模型研究病毒载量、HIV耐药与CD4(+)T细胞计数之间的关系。本研究纳入的参与者年龄为(41.8±10.5)岁。其中,59.9%(5009例)为男性。总人群中CD4(+)T细胞计数<200个/μl的比例为17.9%(1496例),最高的是病毒载量≥1000拷贝/ml且耐药的患者,为43.0%(397/923),其次是病毒载量50 - 999拷贝/ml且耐药的患者,为31.1%(69/222),最低的是病毒载量50 - 999拷贝/ml且无耐药的患者,为13.2%(273/2068)。与病毒载量50 - 999拷贝/ml且无耐药相比,病毒载量<50拷贝/ml、病毒载量50 - 999且耐药、病毒载量≥1000拷贝/ml且无耐药以及病毒载量≥1000拷贝/ml且耐药的患者中,CD4<200个/μl的比值比(95%)分别为0.9(0.7 - 1.0)、3.2(2.3 - 4.4)、2.6(2.1 - 3.2)和4.9(4.0 - 5.9)。在222例病毒载量50 - 999且有HIVDR的患者中,最常见的抗逆转录病毒药物是EFV和NVP,二者均为非核苷类逆转录酶抑制剂(NNRTI),比例均为9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验